CFRX News and Press, ContraFect Corporation From 01/31/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lucid Motors (NASDAQ: LCID ) stock is in the news Tuesday as investors react to a new price target for the company’s shares. Morgan Stanley analyst Adam Jonas is behind today’s news with a price target of...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Sergii Chernov / Shutterstock.com Expion360 (NASDAQ: XPON ) stock is falling on Tuesday as investors react to changes in leadership at the lithium-ion battery company. The first big change is Brian Schaffn...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Blue Planet Studio/Shutterstock Sidus Space (NASDAQ: SIDU ) stock is falling on Tuesday after the satellite company revealed the pricing of its public offering. That public offering has Sidus Space selling...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: arfa adam / Shutterstock.com ContraFect (NASDAQ: CFRX ) stock is rising higher on Tuesday as investors await news about its potential delisting from the Nasdaq Capital Market . ContraFect last updated i...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com Get ready for another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! Moving stocks this morning are a debt deal, delisting news, leadershi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Peshkova Buzzfeed (NASDAQ: BZFD ) stock is rising on Friday on reports that the company will use AI to generate content . According to an internal memo, Buzzfeed is planning to make use o...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Connect world / Shutterstock.com GeneDx (NASDAQ: WGS ) stock is taking a beating on Friday after the company revealed a proposed public stock offering . According to a press release, GeneDx intends to rai...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: arfa adam / Shutterstock.com ContraFect (NASDAQ: CFRX ) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market . ContraFect notes in a ...

YONKERS, N.Y., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life...

Clinical-stage biotechnology company ContraFect ( NASDAQ: CFRX ) is set to purchase ~$7M of its common stock. The company has entered into a securities purchase agreement with a single institutional investor for the purchase. CFRX has agreed to issue 4,350,000 shares and and ...